Monte Rosa Therapeutics (GLUE) SEC Filings: History & Chart

Monte Rosa Therapeutics, Inc.(GLUE)

Biotechnology · Boston, MA

$9.83-0.44 (-4.28%)

Delayed quote: Oct 6, 2026, 1:35 PM EDT

About Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering novel, small-molecule precision medicines. Their core approach involves leveraging the body's inherent mechanisms to precisely eliminate therapeutically relevant proteins. Among their key initiatives is an oral molecular glue degrader designed to target GSPT1, a specific translational termination factor and degron-containing protein, with the aim of treating Myc-driven cancers. The company's pipeline further includes programs for CDK2 in ovarian, uterine, and breast cancers, alongside NEK7 for addressing a spectrum of inflammatory conditions such as Crohn's disease, neurodegenerative ailments, diabetes, and liver disease. Moreover, VAV1 is being explored as a target for autoimmune disorders, and BCL11A, a protein holding significant therapeutic relevance, is under investigation for hemoglobinopathies. Founded in 2019, Monte Rosa Therapeutics, Inc. operates from its headquarters in Boston, Massachusetts.

Boston, MA

173 employees

www.monterosatx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Markus Warmuth

View full financials

Form	Filing Date	Accepted	Document
8-K	Oct 1, 2026	Oct 1, 2026	View filing
8-K	Sep 8, 2026	Sep 8, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
SC 13G	Aug 14, 2026	Aug 14, 2026	View filing
10-Q	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
4	Jul 17, 2026	Jul 17, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
SC 13G/A	Jul 8, 2026	Jul 8, 2026	View filing
4	Jul 7, 2026	Jul 7, 2026	View filing
4	Jul 6, 2026	Jul 6, 2026	View filing
SC 13D/A	Jul 6, 2026	Jul 6, 2026	View filing
4	Jul 1, 2026	Jul 1, 2026	View filing
4	Jun 30, 2026	Jun 30, 2026	View filing
4	Jun 30, 2026	Jun 30, 2026	View filing
4	Jun 25, 2026	Jun 25, 2026	View filing
4	Jun 25, 2026	Jun 25, 2026	View filing
4	Jun 25, 2026	Jun 25, 2026	View filing
4	Jun 18, 2026	Jun 18, 2026	View filing
4	Jun 18, 2026	Jun 18, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
8-K	Jun 11, 2026	Jun 11, 2026	View filing
4	Jun 2, 2026	Jun 2, 2026	View filing
4	Jun 1, 2026	Jun 1, 2026	View filing

SEC Filings

Recent Filings